Rousselot, Darling Ingredients’ collagen and gelatin brand, will present the findings of the first clinical study conducted on its Nextida GC supplement addressing post-meal glucose spikes. The Nextida platform is a range of collagen peptide compositions with targeted health benefits. “We’re immensely excited to take our new step toward decoding the collagen molecule with the release of this first study,” says Jeroen Colpaert, executive VP of Rousselot.
